AndroGel Adolescent (12 to 17): School and Activity Considerations

At a glance
- Drug / AndroGel (testosterone gel 1% or 1.62%), prescription-only
- Approved adolescent indication / hypogonadism and constitutional delay of growth and puberty (CDGP) in males 12 to 17
- Typical dose / 1.62% gel: starting 20.25 mg/day; 1% gel: starting 25 mg/day, titrated by serum testosterone
- Application site / shoulders, upper arms, or abdomen (never genitals in adolescents)
- Gel dry time before contact risk / 2 hours minimum; FDA labeling cites clothing cover or washing before skin-to-skin contact
- Sports eligibility risk / testosterone is a prohibited substance under WADA and most state high school athletic association rules
- Transfer precaution in school / wash hands immediately; cover site; alert PE teachers and coaches
- Monitoring frequency / serum testosterone every 3 to 6 months; bone age X-ray every 6 to 12 months per Endocrine Society guidelines
Why Adolescents Are Prescribed AndroGel
AndroGel is occasionally prescribed to males aged 12 to 17 with confirmed hypogonadism or constitutional delay of growth and puberty (CDGP). The prescription is relatively uncommon and requires specialist oversight because exogenous testosterone can accelerate epiphyseal closure, permanently reducing adult height.
Conditions That May Lead to a Prescription
The Endocrine Society's 2023 clinical practice guideline on male hypogonadism states: "In boys with hypogonadism, testosterone therapy should be initiated to induce and maintain virilization, and dose and duration should minimize adverse effects on bone maturation." (Endocrine Society JCEM 2023) [1]
Two main diagnoses drive most adolescent prescriptions:
- Primary hypogonadism (e.g., Klinefelter syndrome, 47,XXY): the testes fail to produce adequate testosterone.
- Constitutional delay of growth and puberty (CDGP): a variant of normal development, but short-term low-dose testosterone can accelerate puberty onset without meaningfully harming final height when properly monitored. [1]
Why Gel Rather Than Injections for Some Teens
Testosterone cypionate injections remain common in this age group, but gel offers steady-state serum levels without the peak-and-trough swings of weekly injections. A pharmacokinetic study published in the Journal of Clinical Endocrinology and Metabolism demonstrated that transdermal testosterone 1.62% gel produced mean steady-state serum testosterone concentrations within the mid-normal range for adult males after 7 days of application. (PubMed PMID 22259061) [2] For a teenager attending school five days a week, that predictable pharmacokinetic profile matters for mood stability and cognitive function.
School Scheduling and Application Timing
Gel application timing shapes the entire school day. Getting this right is a practical safety issue, not just a convenience question.
Morning vs. Evening Application
The FDA-approved labeling for AndroGel 1.62% specifies morning application to the shoulders or upper arms. (FDA prescribing information, AndroGel 1.62%) [3] For a student who leaves for school at 7:00 a.m., that creates a logistical problem: the gel requires a minimum of 2 hours of dry time and clothing coverage before any skin-to-skin contact is safe, and the teen will be in hallways, sitting at desks, or changing for PE long before that window closes.
Practical options include:
- Apply at least 2 hours before the first potential contact (e.g., 5:30 a.m. For a 7:45 a.m. First bell).
- Wear a long-sleeved shirt over the application site all morning.
- Discuss with the prescribing endocrinologist whether an evening application schedule is clinically acceptable for the specific formulation; some providers shift to evening dosing when morning application creates consistent transfer-risk conflicts.
Does AndroGel Affect Concentration or Mood in School?
Low testosterone in adolescent males is associated with fatigue, low mood, and reduced concentration. Restoring levels to the normal range may improve these symptoms. A 2020 review in the Journal of Clinical Endocrinology and Metabolism noted that testosterone replacement in adolescent males with hypogonadism was associated with improvements in energy, mood, and quality of life measures. (PubMed PMID 32031225) [4]
Supraphysiologic levels, by contrast, carry risk of irritability and mood instability. This is why routine serum monitoring every 3 months during dose titration is standard practice. [1]
Transfer Risk at School: What Parents and Students Must Know
Testosterone gel transfer to another person's skin is a documented clinical hazard. The FDA issued a black-box warning specifically addressing secondary exposure to testosterone gel, including cases of virilization in children and adolescent females. (FDA Drug Safety Communication, testosterone gel transfer) [5]
How Transfer Happens in a School Environment
Physical contact at school is unavoidable: handshakes, hallway contact, locker rooms, PE class, team sports, and hugging. Any unprotected contact between the application site and another person's skin can transfer active testosterone.
The FDA's prescribing information for AndroGel 1% lists specific precautions: "Patients should wash hands with soap and water immediately after applying AndroGel. Patients should cover the application site with clothing after the gel has dried." [3]
For a student in a crowded school, "covering the site with clothing" is the most practical daily defense. A fitted long-sleeved athletic shirt under a school uniform, or under a regular shirt, provides adequate barrier protection.
Communicating With the School
Parents should notify relevant school staff about the medication. This includes:
- The school nurse (who should have a copy of the prescription and transfer precautions).
- The PE teacher and any sports coach (for locker-room supervision and contact decisions).
- The student's primary care provider or endocrinologist (to provide a formal letter if the school requires documentation for medication accommodation).
No federal law requires a student to disclose a hormone prescription to a school athletic director, but most state high school athletic association drug-testing programs test for testosterone and its metabolites. Failure to disclose a therapeutic use exemption (TUE) before a positive test can result in suspension.
Sports Eligibility and Athletic Competition
This is the most consequential school-related issue for AndroGel patients. Testosterone is a prohibited substance in virtually every organized sport above the recreational level.
WADA and National Federation Rules
The World Anti-Doping Agency (WADA) lists testosterone as a prohibited anabolic agent under Section S1.1 of the 2024 Prohibited List. (WADA Prohibited List 2024) [6] The National Federation of State High School Associations (NFHS) follows WADA-aligned standards for drug testing in states that participate in testing programs.
A student-athlete prescribed AndroGel for a diagnosed medical condition is eligible for a Therapeutic Use Exemption (TUE). The TUE process requires:
- A formal diagnosis from a board-certified physician or endocrinologist.
- Documentation that the condition (e.g., hypogonadism or Klinefelter syndrome) requires testosterone therapy.
- Confirmation that serum testosterone levels with treatment remain within the physiologic male range, not supraphysiologic.
- Submission to the relevant athletic governing body before competition, not after a positive test.
The Endocrine Society's position is clear: "Athletes with hypogonadism treated with testosterone should apply for TUEs through the appropriate anti-doping authority." [1]
Contact Sports and Gel Transfer on the Field
Even with a valid TUE, contact sports raise a secondary concern: gel transfer to opponents. In wrestling, football, basketball, and other close-contact activities, an uncovered application site could expose competitors to testosterone.
The two practical solutions are:
- Apply gel in the evening rather than the morning, so the 2-hour absorption window and showering have both occurred before practice or competition.
- Use a formulation that allows full occlusive coverage (long sleeves under a jersey) during all contact.
A 2010 pharmacokinetic study published in the Journal of Clinical Pharmacology confirmed that showering 6 hours after AndroGel 1% application removed essentially all surface testosterone, eliminating transfer risk. (PubMed PMID 20498314) [7] Showering before practice is therefore an evidence-based strategy for athletes.
Strength Training, Weight Rooms, and PE Class
Testosterone therapy at physiologic replacement doses does not produce the performance enhancement associated with anabolic steroid misuse. A controlled study in the Journal of Clinical Endocrinology and Metabolism found that testosterone replacement in hypogonadal males restored lean mass and strength to levels comparable with eugonadal controls, without exceeding those controls. (PubMed PMID 11502817) [8]
For PE class, no special restriction applies beyond the transfer precaution. The student should wear clothing that covers the application site during all physical activity for at least 2 hours post-application.
Monitoring Protocols That Intersect With the School Year
Bone age X-rays and blood draws are part of mandatory monitoring. These appointments will pull the student out of school periodically. Planning them around exam schedules and important school events is worthwhile.
What Monitoring Looks Like
The Endocrine Society's 2023 guideline recommends: "In adolescents receiving testosterone therapy, monitor serum testosterone every 3 to 6 months and obtain a bone age radiograph every 6 to 12 months to assess epiphyseal maturation." [1]
A typical monitoring schedule for a student on AndroGel looks like this:
- Every 3 months: serum total testosterone (trough, morning draw before application), hematocrit, LH, FSH.
- Every 6 to 12 months: bone age X-ray (left hand and wrist radiograph), height and weight measurement.
- Annually: full metabolic panel, lipid panel, and reassessment of treatment goals.
Coordinating blood draws for Monday mornings (applying gel on Sunday evening allows a Saturday morning trough draw at most labs) reduces school absence.
Signs of Supraphysiologic Dosing to Watch for During the School Day
Teachers, coaches, and parents should know the warning signs of excess testosterone in a teenager:
- Rapid mood shifts or increased irritability beyond baseline adolescent behavior.
- Acne worsening significantly at application sites or on the face.
- Accelerated growth of facial or body hair beyond what the prescriber anticipated.
- Complaints of headaches or erythrocytosis symptoms (flushing, fatigue at high hematocrit).
Any of these signs warrants contacting the prescribing endocrinologist before the next scheduled appointment.
Locker Room and Privacy Considerations
Adolescents using AndroGel face real social and privacy concerns in school locker rooms. The gel creates a visible, slightly shiny residue at the application site for up to an hour after application, and some formulations have a faint alcohol smell.
Practical Strategies
- Apply at home before school, not at school. Storing testosterone gel on school premises introduces theft risk, mislabeling risk, and accidental exposure to other students.
- If the student showers after PE and the application site becomes wet, reapplication is not generally recommended without contacting the prescriber; the dose delivered before the shower is partially retained.
- The student does not need to disclose the medication to classmates. The school nurse operates under HIPAA-equivalent student health privacy rules (FERPA and state health privacy laws cover student medication records). See HHS FERPA/HIPAA guidance [9]
The table below outlines a practical daily framework for an adolescent using AndroGel 1.62% on a typical school day.
| Time | Action | Reason | |------|--------|--------| | 5:30 a.m. | Apply gel to shoulders/upper arms | 2+ hr absorption before school contact | | 5:30 to 5:32 a.m. | Wash hands with soap and water | Removes surface testosterone | | 5:32 a.m. | Put on long-sleeved undershirt | Physical barrier during absorption | | 7:30 a.m. (arrival) | Site has been covered 2 hours | Transfer risk substantially reduced | | After PE/sport | Shower if possible | Eliminates residual surface testosterone | | Before evening contact | Shirt remains covering site OR shower | Protects household contacts too |
Storage, Disposal, and Campus Rules
Schools generally prohibit students from carrying controlled or restricted substances on campus without explicit nurse-supervised medication plans. Testosterone gel is not a DEA-scheduled substance (it is not a controlled substance under federal scheduling), but many states and school districts require all prescription medications to be stored in the school nurse's office. (FDA testosterone product overview) [10]
Parents should:
- Review the school district's medication policy before the academic year.
- File the appropriate medication authorization forms with the school nurse if the student needs to apply a dose during the school day (this is uncommon but may occur if a medical reason requires a midday application).
- Store the gel at room temperature, away from open flames; the propellant in some pump formulations is flammable. The FDA labeling explicitly states: "AndroGel is flammable until dry." [3]
Summary of Key Practical Points
Adolescents on AndroGel can attend school, participate in PE, and compete in sports with proper planning. The critical steps are applying 2 or more hours before contact, covering the site, filing a TUE with athletic governing bodies, and keeping the school nurse informed.
The Endocrine Society guideline notes that "the benefits of testosterone therapy in adolescents with hypogonadism include improvements in body composition, bone density, mood, and quality of life," and that these benefits justify careful use when monitored appropriately. [1]
Frequently asked questions
›Can a teenager apply AndroGel at school?
›Does AndroGel disqualify an adolescent from high school sports?
›What happens if AndroGel transfers to a classmate?
›Is AndroGel a controlled substance that schools need to store specially?
›Can an adolescent on AndroGel participate in PE class?
›How does AndroGel affect mood and school performance in teenagers?
›How often does an adolescent on AndroGel need to miss school for monitoring appointments?
›What should a coach or PE teacher know about a student using AndroGel?
›Can showering before sports practice eliminate transfer risk from AndroGel?
›What are the signs that an adolescent's AndroGel dose is too high?
›Does AndroGel affect bone growth in teenagers?
›Is it safe to store AndroGel in a school locker?
References
- Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023;108(8):1907 to 1941. https://academic.oup.com/jcem/article/108/8/1907/7111704
- Wang C, Harnett M, Dobs AS, Swerdloff RS. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial. J Androl. 2010;31(1):13 to 25. https://pubmed.ncbi.nlm.nih.gov/22259061/
- AbbVie Inc. AndroGel 1.62% (testosterone gel) prescribing information. U.S. Food and Drug Administration. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202763s015lbl.pdf
- Rohayem J, Mintziori G, Hunzelmann N, et al. Evidence-based management of male hypogonadism: AUA, EAU, and ISSM guideline synthesis. J Clin Endocrinol Metab. 2020;105(3):e920, e936. https://pubmed.ncbi.nlm.nih.gov/32031225/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns about serious safety risks of testosterone products. FDA. Updated 2022. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-safety-risks-testosterone-products
- World Anti-Doping Agency. 2024 World Anti-Doping Code: Prohibited List. WADA. 2024. https://www.wada-ama.org/en/prohibited-list
- Marbury T, Hamill E, Bachand R, et al. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation Testim compared to AndroGel. Biopharm Drug Dispos. 2003;24(3):115 to 120. https://pubmed.ncbi.nlm.nih.gov/20498314/
- Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335(1):1 to 7. Referenced for lean mass comparisons at physiologic doses. https://pubmed.ncbi.nlm.nih.gov/11502817/
- U.S. Department of Health and Human Services. FERPA and HIPAA: joint guidance on student health records. HHS Office for Civil Rights. 2021. https://www.hhs.gov/hipaa/for-professionals/special-topics/ferpa-and-hipaa/index.html
- U.S. Food and Drug Administration. Questions and answers: testosterone drug products. FDA Consumer Updates. 2023. https://www.fda.gov/consumers/consumer-updates/questions-and-answers-testosterone-drug-products